Open Actively Recruiting

The Use of Feraheme as MRI Contrast Agent in Patients with CKD

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Eligibility

Minimum Age
N/A
Maximum Age
N/A
Share:
Study Stats
Protocol No.
13-001341
Category
Genitourinary Disorders
Heart/Cardiovascular Diseases
Pediatric Disorders
Contact
Viktor Sigalov
Location
  • UCLA Westwood